Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Telix Pharmaceuticals (NASDAQ:TLX) through any online brokerage.
Other companies in Telix Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Telix Pharmaceuticals has a consensus price target of $21.20.
The stock price for Telix Pharmaceuticals (NASDAQ: TLX) is $11.13 last updated October 13, 2026 at 5:11 PM EDT.
There are no upcoming dividends for Telix Pharmaceuticals.
Telix Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Telix Pharmaceuticals.
Telix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.